(Q43416735)

23 November 2017

title

Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations (English)

1 reference

23 November 2017

0 references

Staphylococcus aureus

1 reference

1

Michael R Mulvey

1 reference

23 November 2017

Malcolm Doupe

2

1 reference

23 November 2017

Michael Prout

3

1 reference

23 November 2017

Christine Leong

4

1 reference

23 November 2017

Romeo Hizon

5

1 reference

23 November 2017

Amy Grossberndt

6

1 reference

23 November 2017

Meghann Klowak

7

1 reference

23 November 2017

Aneri Gupta

8

1 reference

23 November 2017

Maria Melanson

9

1 reference

23 November 2017

Andrew Gomori

10

1 reference

23 November 2017

Farid Esfahani

11

1 reference

23 November 2017

Loressa Klassen

12

1 reference

23 November 2017

Emma E Frost

13

1 reference

23 November 2017

Michael Namaka

14

1 reference

23 November 2017

publication date

6 January 2011

1 reference

Multiple Sclerosis Journal

23 November 2017

published in

1 reference

23 November 2017

volume

17

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

397-403

1 reference

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Mechanisms for the induction of autoimmunity by infectious agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Superantigen reactivity of gamma delta T cell clones isolated from patients with multiple sclerosis and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Immune response to staphylococcal superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Observations of the staphylococcal nasal carrier state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Nasal carriers of coagulase-positive staphylococci in a Nigerian hospital community

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Determinants of Staphylococcus aureus nasal carriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

The natural history of relapses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Staphylococcal vaccines and immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510391343

21 January 2018

Identifiers

DOI

10.1177/1352458510391343

1 reference

23 November 2017

1 reference